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We aimed to characterize the genetic constitution of natural T. cruzi populations involved
in an Oral Chagas Disease (OCD) outbreak at a rural school of the community of
Chichiriviche de la Costa, Venezuela, which affected patients did not respond to the
etiological treatment. Peripheral blood samples and/or hemocultures were obtained from
twenty-nine OCD patients at time of diagnosis or along nine years of Post-treatment (Tx)
follow-up. The IgG serology, T. cruzi discrete typing units (DTU), satellite DNA-qPCR
parasitic loads, and minicircle signatures were determined at Pre-Tx and after Tx. The
serological titles and parasitic loads changed after treatment, with a significant decrease of
IgG titers (Spearman’s r value= -0.961) and median parasite loads from 2.869 [IQR =
2.113 to 3.720] to 0.105 [IQR = -1.147 to 1.761] log10 par eq. /mL at Pre-Tx and Post-Tx,
respectively, suggesting infection evolution from acute to chronic phase, without
seroconversion or parasitological eradication, which was indicative of treatment failure.
All patients were infected with T. cruzi DTU I populations. At Pre-Tx their median Jaccard
genetic distances were 0.775 [IQR = 0.708 to 0.882], decreasing in genetic variability
towards the end of follow-up (Mann-Whitney U test p= 0.0031). Interestingly, no Post-Tx
minicircle signature was identical to its Pre-Tx counterpart population in a same patient,
revealing selection of parasite subpopulations between the primary infection and Post-Tx.
The parasitic populations isolated from hemocultures showed a lower number of bands in
the minicircle signatures with respect to the signatures obtained directly from the patients’
blood samples, demonstrating a process of parasitic selection and reduction of the
population variability that initially infected the patients. Decrease of parasitic loads after
treatment as well as Pre- and Post-Tx intra-TcI diversity might be a consequence of both,gy | www.frontiersin.org April 2021 | Volume 11 | Article 6650631
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Chagas disease (CD), caused by Trypanosoma cruzi affects
mostly populations living in poor housing conditions in Latin
America (Pereiro, 2019). Although initially considered
transmitted mostly by triatomine bugs, the parasite can be
transmitted by other routes, one of the most important in
recent decades being oral transmission, as a result of
contamination of food with feces of wild triatomines or
secretions from reservoirs in endemic regions (Rueda et al.,
2014; Alarcón de Noya et al., 2015).
Venezuela is the third country with oral Chagas disease
(OCD) reports since 2007, and the first one with the most
numerous OCD micro-epidemics (Alarcón de Noya et al.,
2015). The first outbreaks were associated with consumption of
guava (Psidium guajava) juice in an urban school in the Chacao
Municipality (Caracas, Capital District) in 2007 (Alarcon de
Noya et al., 2010) and the second in a rural school in the
community of Chichiriviche de la Costa (Vargas State)
(Alarcon de Noya et al., 2016) in 2009, with varied degree of
disease severity and mortality (Alarcón de Noya et al., 2015;
Alarcon de Noya et al., 2016).
In Chichiriviche de la Costa, a small tourist town nestled
between mountains and on the shores of the Caribbean Sea,
located on the north-central coast of Venezuela, there were
simultaneous cases of fever and myocarditis in students,
teachers, and administrative staff of the local school (10°31′
53.97″N - 67°15′36.02″W). These clinical findings led to the
serological screening of specific anti-T. cruzi IgM and IgG
reactivities to 441 people, resulting in 89 infected people and
mortality associated with acute T. cruzi infection in 5.6% of them
(Alarcón de Noya and Martinez, 2009; Alarcon de Noya
et al., 2016).
In these patients, the outcome observed by serological,
parasitological and PCR-based monitoring two years after
treatment with Benznidazole (Bnz) was disappointing. Around
70% of patients still had positive lytic antibodies; some presented
anti-T.cruzi IgG antibody titers and positive T. cruzi PCR
findings (Alarcón de Noya et al., 2011). Considering that Bnz
is highly effective in the acute phase and during childhood in
other endemic regions where other parasite DTUs prevail
(Bianchi et al., 2015; Moscatelli et al., 2019), these data
suggested therapeutic failure and consequently a second
treatment was administered to people with persistence of lytic
antibodies and/or positive PCR results, however without
outcome improvement (Garcia-Bournissen, 2019; Molina-
Morant et al., 2020).
It is crucial to carry out genetic studies on parasitic
populations involved in OCD aiming to seek an explanationgy | www.frontiersin.org 2for the differences in Bnz efficacy with respect to other
epidemiological settings. In assessing drug efficacy, in vitro
susceptibility tests carried out in parasite isolates obtained at
pre-treatment (Pre-Tx) and Post-treatment (Post-Tx) from these
outbreaks displayed clones naturally less susceptible to Bnz and
Nfx (Muñoz-Calderón et al., 2012; Muñoz-Calderón et al., 2019).
Indeed, the genetic polymorphism of T. cruzimay be involved in
its susceptibility to anti-parasitic drugs. However, genetic studies
of natural parasite populations in CD patients exhibiting
treatment failure have not been done so far. In this context,
peripheral blood samples and hemocultures obtained from OCD
patients at Chichiriviche de la Costa outbreak were analyzed at
time of diagnosis and after Tx, attempting to detect and
characterize fluctuations of T. cruzi genetic diversity and
parasitic loads along the follow-up.METHODS
Ethics Statement
The study was approved by the Ethical Review Board of the
Instituto de Medicina Tropical “Dr Félix Pifano”-Universidad
Central de Venezuela, Caracas, Venezuela (CEC-IMT 019/2010 -
December 10, 2010); following the principles expressed in the
Declaration of Helsinki.
Written informed consent forms were signed by each
participant or from their legal guardians (minor subjects were
included). Samples were anonymized before being processed.
Patients and Samples
The study population consisted of students, teachers, school
workers and outsiders involved in the preparation or
transportation of food consumed in schools, and anyone
considered as a potential at-risk “school contact”. The
participants eligible for the study were 29 patients who
presented positive anti-T. cruzi IgG antibody titers or
kinetoplastid DNA-PCR amplification after nine years of Post-
Tx follow-up, according to data provided by the Instituto de
Medicina Tropical “Dr Félix Pifano”- Universidad Central de
Venezuela, Caracas, Venezuela.
Table 1 shows epidemiological features of the study patients
from the Chichiriviche de la Costa outbreak, hemocultures
obtained, number of blood samples analyzed and Post-Tx time
period of each sample. Additionally, the distribution of the
number of samples for each of the variables studied in this
work (Pre-treatment and Post-treatment points), is outlined in
Figure 1.April 2021 | Volume 11 | Article 665063
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Patients with acute OCD were clinically classified with
i) moderate symptoms whose clinical situation allowed them to
continue with work activities (facial edema; dyspnea; abdominal
pain; headache; arthralgia; myalgia; asthenia; drowsiness;
headache; intraocular pain; rash; echocardiogram (ECHO):
Supraventricular hypertrophy), and ii) severe symptoms who
had to be hospitalized or deceased (ECHO: pericardial effusion
or myocarditis; electrocardiogram (EKG): supraventricular
arrhythmia or supraventricular hypertrophy; adenomegaly;
cardiomegaly; tachycardia).Antiparasitic Treatment
Patients were treated with Bnz (6 mg/kg/day) during 60
continuous days in three daily doses (Alarcón de Noya et al.,
2011; Alarcon de Noya et al., 2016). During follow-up, nine
treated patients who remained with evidence of parasite
persistence (high values in anti-T. cruzi IgG titers, presence of
lytic antibodies, and/or persistence of positive PCR) received a
new course of treatment with Bnz (Amato Neto, 1999).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3Laboratory Diagnosis
At each visit, a single peripheral blood sample was withdrawn by
venipuncture. Five milliliters were dedicated to serum collection
to perform IgG-based serological analyses. The remaining
volume was used for molecular biology studies.
Immunoenzymatic Assay
An in-house immunoenzymatic assay (ELISA) was performed
using a delipidized antigenic lysate obtained from the
epimastigote stage of the T. cruzi “PM” strain (TcI) and
processed using Maxisorp plates. ELISA tests involving anti-
human IgG alkaline phosphatase conjugates were carried out
simultaneously in all sera. ELISA IgG cut-off line was defined as
an optical density (OD) value equal to 0.200 to determine a
positive sample (Alarcón de Noya et al., 2011).
Preparation of Samples for Molecular
Biology Studies
Five mL of patients’ peripheral blood was mixed with an equal
volume of 6M Guanidine HCl/0.2 mM EDTA, pH 8.00 (GEB)TABLE 1 | Description of the Oral Chagas Disease patients´ cohort with Pre and Post treatment follow-up samples for 9 years.














P1 Blood 10 F TcI Severe Bnz 5 N/A
P2 Blood 7 F TcI Severe Bnz 5 N/A
P3 Blood 8 F TcI Moderate Bnz 4 N/A
P4 Blood 9 F TcI Severe Bnz 3 N/A
P5 Blood 9 F TcI Severe Bnz Bnz+ 5 N/A
P6 Blood 7 F TcI Severe Bnz 4 N/A
P7 Blood/
Hemoculture
8 M TcI Moderate Bnz Bnz+ 5 Pre-Tx
P8 Blood 10 F TcI Severe Bnz 4 N/A
P9 Blood 9 F TcI Severe Bnz 4 N/A
P10 Blood 10 M TcI Moderate Bnz 4 N/A
P11 Blood 10 M TcI Severe Bnz Bnz+ 4 N/A
P12 Blood 9 M TcI Severe Bnz 4 N/A
P13 Blood 6 M TcI Severe Bnz 4 N/A
P14 Blood 7 M TcI Severe Bnz 3 N/A
P15 Blood 7 M TcI Severe Bnz Bnz+ 4 N/A
P16 Blood 8 M TcI Severe Bnz 4 N/A
P17 Blood 9 M TcI Severe Bnz 4 N/A
P18 Blood 11 F TcI Severe Bnz 4 N/A
P19 Blood 16 M TcI Severe Bnz 4 N/A
P20 Blood 11 F TcI Severe Bnz 4 N/A
P21 Blood/
Hemoculture
36 M TcI Severe Bnz 4 Pre-Tx
P22 Blood 11 F TcI Severe Bnz 4 N/A
P23 Blood 47 F TcI Severe Bnz Bnz+ 4 N/A
P24 Blood 11 M TcI Severe Bnz 4 N/A
P25 Blood 11 M TcI Severe Bnz 4 N/A
P26 Hemoculture 5 F TcI Severe Bnz Bnz* N/A Pre-Tx
P27 Hemoculture 9 M TcI Severe Bnz Bnz+ N/A 1 year Post-Tx
P28 Hemoculture 10 M TcI Severe Bnz Bnz+ N/A 1 year Post-Tx
P29 Hemoculture 7 F TcI Severe Bnz Bnz* N/A 2 years Post-TxApril 2021 | Volume 11Bnz+ - Second treatment with Benznidazole given 1 year post infection.
Bnz++ - Second treatment with Benznidazole given 4 years post infection.
N/A, Not Applicable.
Bzn, Benznidazole.| Article 665063
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mixture was stored at 4°C; DNA was extracted from 300 µL
aliquots using the High Pure PCR Template Preparation kit
(Roche Diagnostics, Indianapolis, IN) and eluted in 100 µL
elution buffer (Duffy et al., 2013).Parasite Cultures
Epimastigote forms obtained from patients’ hemocultures and
four TcI reference strains (Dm28c, SilvioX10, gal4, and CMA)
were cultured in LIT medium (supplemented with 5% bovine
fetal serum) and sub-cultured every 15 days during the
exponential growth phase.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4DNA Extraction and Quantitative Analysis
Parasites were collected at logarithmic phase and centrifuged at
3000 × g. The High Pure PCR Template Preparation kit (Roche
Diagnostic, Indianapolis, IN) was used for DNA extraction following
the manufacturer’s recommendations. The genomic DNA was then
preserved at 4°C until use. DNA purity and concentration were
determined in a Nanodrop ND-1000 (NanoDrop Technologies,
Houston, TX, USA) at 260/280 nm wavelengths.
kDNA-PCR Amplification
A 330 bp sequence belonging to the hypervariable region of T.
cruzi kDNA was amplified as reported (Schijman et al., 2011).
Briefly, the master mix was composed by 1X Taq platinumA
B
FIGURE 1 | (A) Flowchart for the distribution of study patients´ samples and type of analysis performed. Tx: Treatment. (B) timeline of blood sample collection at
follow-up time.April 2021 | Volume 11 | Article 665063
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1.5 U Taq Platinum (Invitrogen, Brazil), 10 µM kDNA specific
primers 121 (AAATAATGTACGGGKGAGATGCATGA) and
122 (GGTTCGATTGGGGTTGGTGTAATATA), 5 µl of
template DNA, and a quantity of water sufficient to give a final
volume of 50 µl. Cycling parameters were one step of 3 min
denaturation at 94°C; 2 cycles of 1 min at 97.5°C, 2 min at 64°C;
33 cycles of 1 min at 94°C, 1 min at 62°C and one final extension
step of 10 min at 72°C. The kDNA-PCR products were analyzed
in 2% agarose gels stained with ethidium bromide.
Estimation of Parasitic Loads
A standardized duplex quantitative real-time PCR (qPCR)
targeted to T. cruzi Satellite (Sat) DNA and Internal
Amplification control (IAC) was used, under the reported
conditions (Duffy et al., 2013). Standard curves were plotted
with 1/10 serial dilutions of total DNA obtained from the same
stock of a GEB seronegative sample spiked with 1x105 par.eq./mL
of Silvio X10 (TcI) cultured epimastigotes. The reportable linear
range of this qPCR was 1 to 6 log10par eq./mL for TcI-infected
samples (Duffy et al., 2013).
Identification of Trypanosoma
cruzi Discrete Typing Units (DTUs)
A Real-Time PCR-based algorithm for identification of T. cruzi
DTUs was done by means of amplification of spliced-leader
genes, 24Sa rRNA, 18Sa rRNA and COII genomic markers
using TaqMan probes, as described (Cura et al., 2015).
Minicircle Signatures
To identify minicircle signatures (Ms) of bloodstream parasite
populations, kDNA-PCR samples were studied. The 330 bp
purified amplicon was subjected to HindFI, RsaI, and MspI
digestions as reported (Burgos et al., 2010). Signatures were
visualized and digitized using a Syngene ultraviolet light
transilluminator (Synoptics Ltd., Cambridge, UK), at 498 nm.
The sizes of the bands of each signature were determined by
comparison with molecular weight markers included in each
electrophoresis, using the GelAnalyzer v2010a program (http://
www.gelanalyzer.com). To assess the reproducibility of the Ms,
three independent kDNA-PCR experiments from a same DNA
preparation were performed, and each product was digested
on triplicate.
Genetic Distance Determination
Binary matrices were created from each Ms. Only sharp bands
resolved by gel electrophoresis were used in the analysis. Visible
amplified bands were scored as “1”, whereas the absence of bands
of the same molecular weight was scored as “0”. All samples from
a same patient were analyzed in a same gel. The degree of
similarity, i.e. frequency of co-occurrence, between clinical
samples was measured using the Jaccard’s coefficient (JC)
between Pre-Tx and Post-Tx samples for each patient.
In order to estimate the overall variability of the Pre-Tx
parasite populations using as marker the minicircle signatures,
a median value of the Jaccard genetic distances among the pre-Tx
samples was determined, and the profiles obtained from eachFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5sample at the different Post-Tx points were compared against
that pre-Tx median value.
In addition, the minicircle profiles obtained from the
hemocultures were compared among them, in order to obtain
an overall JC sight of the cultured parasite strains and compare
their JCs with those obtained among laboratory reference clones
belonging to Tc I.
Statistical Analysis
A data analysis was performed on the follow-up panel to evaluate
the change in parasite loads, IgG antibody values, Jaccard’s
coefficient, and/or the clinical classification of the patients. The
graphic comparisons between the different variables obtained
from each patient: IgG serology (optical density), parasite load
(Par.eq/mL) and JC, were carried out with a Z score data
transformation. The continuous measurements were expressed
and plotted as the median and interquartile range of 25–75%,
whereas dichotomous variables were expressed and plotted as
a percentage.
For all variables, the normal distributions were evaluated
using the Shapiro-Wilks test. The Spearman’s rank correlation
coefficient was calculated to assess correlations among the
variables under study (parasitemia levels, ELISA IgG values
and patients’ clinical classification). Correlation is stronger as
the value of r approaches 1 for positive correlations or -1 for
negative correlations. To evaluate the differences between Pre-Tx
and Post-Tx follow-up points, the Mann-Whitney U test
was used.
All analyses were performed with the RStudio Team software
(2020), and calculations were determined with a p-value of <0.05
for significant statistical differences.RESULTS
Peripheral blood samples and/or hemocultures obtained from 29
OCD patients at Pre-Tx and/or at different Post-Tx visits were
included in the study (Table 1). From each patient (except P26 to
P29, in which only hemocultures were obtained), one Pre-Tx
sample and Post-Tx samples collected at at least two different
visits were analyzed by serological and molecular tools.
IgG-based Serological Findings and
Parasitic Loads
All study patients were seropositive at Pre-Tx. The Post-Tx
accumulated seropositivity was 82.26% (n = 21) (Figure 2A).
After nine years of Post-Tx, seropositivity was 71.43% (n=15),
with a median in optical density of 0.320 [IQR = 0.174 to 0.507].
Although there was not seroconversion, a trend towards
antibodies titers decrease was observed (Figure 2C).
Out of the 29 study patients, whole blood samples were collected
in 25. In patient P7 and P21 whole blood and a Pre-Tx hemoculture
isolate were obtained. In patients P26 to P29, hemocultures but
not blood were obtained at different follow-up stages, so qPCR
quantification of parasitic loads was not performed.
Overall, 92.06% (116 out of 126 samples) agreement between
kDNA-PCR and satDNA-qPCR findings was foundApril 2021 | Volume 11 | Article 665063
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samples was 100% (n=25), with a median parasite load of 2.869
[IQR = 2.113 to 3.720] log10 par eq./mL (Figures 2B, D). In
approximately one-third of patients, parasitic load fluctuations
above and below the lower reportable range were detected during
follow-up. Despite this, a 92.5% (n=14) cumulative qPCR
positivity was obtained up to nine years Post-Tx (Figure 2B).
During Post-Tx monitoring, a median of the parasite load of
0.105 [IQR = -1.147 to 1.761] log10 par eq./mL was obtained,
which is close to qPCR detection limit (Figure 2D). At 9 years
Post-Tx, 50% (n=8) of the samples remained quantifiable by
qPCR, with a median of the parasite load of 0.028 [IQR = -0.502
to 1.783] log10 par eq./mL. Thus, SatDNA-qPCR was more
sensitive than serological analysis to detect treatment failure,
allowing detection of 28.57% (n=5) more cases of patients who
did not respond to treatment. In sum, treatment failure of
around 85% (n=16) was obtained.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6Serological reactivity decreased during Post Tx follow-up
(Spearman’s r value= -0.961, Figure 3A), whereas parasitic
load showed a slight tendency to decrease at the end of follow-
up (Spearman’s r value= -0.400), however, this trend was not
statistically significant (P value of the Spearman’s rank
correlation coefficient >0.05). Post-Tx parasitic loads showed a
median of 0.105 [IQR = -1.147 to 1.761] Log10 par.eq/mL along
monitoring (Figure 3B).
Characterization of DTUs and
Minicircle Signatures
Bloodstream DTUs were identified in kDNA-PCR positive
samples, resulting all TcI (Table 1). The intra-TcI genetic
composition was characterized by RFLP-PCR of kDNA
amplicons obtained in 41 blood samples from 12 patients at
different follow-up time points, and in the hemocultures isolated
from 6 patients. The Ms exhibited between five and 14 digestionA B
C D
FIGURE 2 | Distribution of anti-Trypanosoma cruzi ELISA-IgG reactivity and SatDNA-qPCR positivity during the follow-up of patients of the Chichiriviche de la Costa
oral Chagas disease outbreak. (A) Cumulative positivity percentage of ELISA-IgG; (B) satDNA-qPCR cumulative positivity percentage; (C) Trend of optical density
values for the ELISA-IgG; (D) Trend of parasitic load values for the satDNA-qPCR. Tx: Treatment. ELISA IgG cutline: Optical Density (OD) value reportable by a
positive sample (Diaz-Bello et al., 2008); TcI load cutline: 1 par eq./mL, lowest value of linear reportable range of qPCR (Duffy et al., 2013). The data in Figures (C)
and (D) are presented as median and interquartile range from 25 to 75%.April 2021 | Volume 11 | Article 665063
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of heterogeneity was observed among different patients`
populations and between Pre-Tx and Post-Tx Ms signatures in
the same patients.
Comparing the JC values, a slight difference in median values,
0.775 [IQR = 0.708 to 0.882] and 0.857 [IQR = 0.798 to 0.941]
were observed in Pre-Tx populations analyzed from clinical
samples or culture isolates, respectively (Figures 5A, B).
However, the Mann-Whitney U test did not show differences
between both types of samples. Out of the 25 Post-Tx Ms profiles
evaluated, none presented 100% homology with the
corresponding Pre-Tx Ms (Supplementary Data), revealing
that parasite populations changed between the time of diagnosis
and times of follow-up. When analyzing the overall T. cruzi
variability between Pre-Tx and Post-Tx follow-up samples,
fluctuations in the degree of polymorphism were observed.
The JC distances decreased respect to Pre-Tx values at 1-2
years and five years Post-Tx (Mann-Whitney U test p<0.0001,
respectively). At 9 years Post-Tx, a slight increase in the JC values
could be observed compared to those obtained in previous Post-
Tx points, however, the difference in values was only significant
when comparing the JC values against the Pre-Tx samples
(Mann-Whitney U test p= 0.0031). The median of the JC
among the three parasite isolates obtained at Pre-Tx was 0.92
and the JC values among the three isolates tested 1-2 years Post-
Tx was 0.84 (Mann-Whitney U test p>0.05). Finally, the JC
values among the Pre-Tx hemocultures obtained from this
outbreak, suggested greater heterogeneity with respect to the
JC values obtained in the four TcI reference strains, without
reaching significant difference (Mann-Whitney U test p>0.05).
The number of Ms restriction fragments from the tested
patients’ parasite populations was counted as an indirect
measure of the degree of clonality of those populations along
follow-up. Different patterns were observed (Figure 6). In fourFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7patients, the number of Ms bands persisted or showed a slight
decrease between Pre-Tx and two years Post-Tx and decreased in
complexity when tested five years Post-Tx (pattern 1), suggesting
clonal selection. The parasitic populations of other four patients
showed an increase in kDNA fragments (pattern 2), which
suggests proliferation of a higher number of parasite clones.
Finally, two patients (P4 and P21) showed no variation in the
number and molecular weights of the Ms restriction fragments of
their parasitic populations, except for differences in the intensity
of some bands (Figure 4).DISCUSSION
This is the first study showing the dynamics of parasitic burden
and genetic diversity of natural T. cruzi populations infecting
OCD patients who did not respond to Bnz treatment after nine
years of follow-up.
The fluctuations in ELISA-IgG titers and parasitic loads after
etiological treatment showed negative Pearson correlation
coefficients with a tendency to negativization. Parasite load
values at nine years Post-Tx were very close to the lowest value
of the qPCR reportable range (Figure 2D). However, no
seroconversion nor persistent PCR negativization was observed,
suggesting a partial parasitological response to Tx, which was even
observed in the nine patients who received two rounds of Bnz.
When analyzing parasite loads, the first stands out was the
heterogeneity observed in Post-Tx values. This could be associated
with the evolution of the infection from its acute phase at time of
diagnosis, to the chronic phase during the follow-up period. Low
bloodstream parasitic loads are typical of the chronic stage, when
parasite persists in tissues according to their clonal histotropism
(Macedo and Segatto, 2010). The immune system plays a
fundamental role in the control of circulating parasite levelsBA
FIGURE 3 | The Spearman’s rank correlation coefficient during Post-Tx follow-up in patients of the Chichiriviche de la Costa oral Chagas disease outbreak. (A) IgG
serology; (B) SatDNA-qPCR parasitic loads. Dotted lines indicate the 95% confidence interval. P value <0.05 indicates the significance of the correlation between
the variables.April 2021 | Volume 11 | Article 665063
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trypomastigotes that are released to the bloodstream (Macedo
and Segatto, 2010), and this can be reflected in the bloodstream
qPCR quantifications. Thus, the observed changes may be more
related to the passage from one infection phase to the other one
than to a selective pressure exerted by chemotherapy, or to a
mixture of both factors.
Following the hypothesis proposed by Alarcón de Noya and
co-authors, that “all individuals were infected by a common source
for each outbreak, based in eco-epidemiological and molecular
genetics studies” (Alarcon de Noya et al., 2010; Munoz-Calderon
et al., 2013; Diaz-Bello et al., 2014; Alarcon de Noya et al., 2016),Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8and identification of TcI DTU in all patients, similarly to what has
been detected in other surveys in Venezuela (Carrasco et al.,
2012), parasite genetic heterogeneity in patients from
Chichiriviche de la Costa was revealed at the intra DTU level
and between Pre-Tx and Post-Tx in a same patient. This is
indicative of polyclonal populations as sources of oral infection
in this outbreak. In fact, in food contaminated with triatomines
feces, all metacyclic trypomastigotes present in the intestinal
content of the triatomines are involved. It is estimated that a
single fecal sample may contain between 3000 to 4000
trypomastigotes per microliter, thus a high clonal complexity
may exist (Schaub, 1989).B C
A
FIGURE 4 | Profile of minicircle signatures in parasite populations by kDNA-PCR restriction fragment polymorphism (RFLP). (A) Example of comparative band
analysis of minicircle profiles obtained by RFLP-PCR between patients’ parasite populations; (B) Boxplot distribution of number bands obtained by RFLP-PCR
throughout the follow-up in the blood samples. (C) Distribution of the boxplot of number of digestion fragments obtained by RFLP-PCR in Trypanosoma cruzi
isolates obtained from hemocultures and TcI reference strains. 1: Reference strain (DTU I - Dm28c); 2-3: Sample P1 (Pre-Tx and 5 years Post-Tx); 4-5: Sample P10
(Pre-Tx and 5 years Post-Tx); 6-7: Sample P11 (Pre-Tx and 5 years Post-Tx); 8-9: Sample P15 (Pre-Tx and 5 years Post-Tx); 10-11: Sample P29 (Pre-Tx culture
isolate and 1 year Post-Tx culture isolate); 12-14: Sample P4 (Pre-Tx, 5 years and 9 years Post-Tx); 15-17: Sample P21 (Pre-Tx, 5 years and 9 years Post-Tx). The
JC results shown in the box “reference strains” were obtained from the comparison of the Ms from the Dm28c, SilvioX10, gal4, and CMA strains. P value indicates
significant differences between populations (Mann-Whitney U test; p<0.05). Data in the boxplot are presented as median and interquartile range of 25 to 75%.April 2021 | Volume 11 | Article 665063
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resistant clones to chemotherapeutic drugs, therefore destruction
of susceptible forms by drugs leads to the selection and
proliferation of resistant subpopulations (Noya et al., 2015). In a
subgroup of patients whose parasite populations decreased or
persisted in clonal complexity after Tx, suggested by the quantity
of minicircle restriction fragments of different lengths, it is
tempting to speculate that some drug-driven selection pressure
could have played a role in subpopulations selection. (Ms patterns
1 and 3; Figure 6). Interestingly, parasite culture isolate from
patient P21 harbored a truncated Nitroreductase protein sequence,
with a putative role in drug resistance (Unpublished data).
In vitro susceptibility studies carried out with T. cruzi strains
isolated from the patients of the Chacao outbreak showed high
heterogeneity in IC50 values against Nfx, suggesting that the
therapeutic failure could be due in part to a phenotypic
variability extant in the original parasite source of oral
transmission (Muñoz-Calderón et al., 2019). These findings,
together with the high heterogeneity found between Pre-Tx
and Post-Tx follow-up bloodstream T. cruzi populations of this
outbreak are compatible to the existence of drug-driven
selective pressure.
On the other side, clonal selection may occur in the natural
development of T. cruzi infection from its acute to its chronic
phase. Indeed, clones capable to escape from the host’s immune
system are the ones to proliferate in the chronic phase. The
median of the parasitic loads of 0.105 [IQR = -1.147 to 1.761]
log10 par eq./mL observed during follow-up are typical of
chronic infection. In four patients (P10, P11, P17, and P25) an
increase in Ms polymorphism at some point in the Post-Tx
follow-up was observed. In general, it is assumed that a higher
number of minicircle bands is indicative of a higher level of
clonality (Burgos et al., 2010). In all cases, as the JC value withFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9respect to the Pre-Tx Ms is high, it can be hypothesized that the
subpopulations proliferating after treatment were hidden into
the tissues during treatment. In these particular cases, it could be
attributed to possible reinfections, since the area is a region with
a risk of active vector transmission (Noya et al., 2015).
A point to be highlighted is that the characterized parasitic
populations correspond to bloodstream parasites. However, it is
not possible to analyze the genetic diversity of parasites housed
in tissues. Sánchez-Valdéz et al. (2018) showed for the first time
that T. cruzi enters a dormant state, i.e. some amastigotes can
interrupt their cellular replication during an in vitro infection
(Thomas et al., 2018; Alonso-Padilla et al., 2020). This
characteristic in bacteria and other protozoa has been related
to the recurrence of infection or drug resistance (Sánchez-Valdéz
et al., 2018). Therefore, the appearance of different parasite
populations in the Post-Tx samples of OCD patients respect to
their Pre-Tx populations could also be associated with this
feature. Accordingly, we could have been identifying the
genetic diversity of intracellular parasite populations that
survived in an environment where the drug concentration was
lower and they were not necessarily resistant clones. This could
be the case for those patients who showed an increase in parasite
variability after Tx. On the other hand, dormancy would not be
so relevant in TcI strains, at least compared to other DTUs, as
reported by Resende et al. (2020).
The limited sample size of the patients for each of the time
points evaluated (Pre-Tx, 1-2 years, 5 years and 9 years Post-Tx)
has been a study limitation, mainly influenced by the difficulty of
extracting parasitic gDNA from blood samples in patients at the
chronic phase of Chagas disease. Additionally, the lack of a
placebo group limits the analysis of the genetic variability of
parasitic populations when evolving from the acute phase to the
chronic phase of the disease. The inclusion of a placebo groupBA
FIGURE 5 | Jaccard distances of minicircle signatures in parasite populations by kDNA-PCR restriction fragment length polymorphism (RFLP). (A) Jaccard
distances from bloodstream parasites populations in patients of the Chichiriviche de la Costa outbreak. (B) Jaccard distances of the hemocultures from the
Chichiriviche de la Costa outbreak and TcI reference strains. Reproducibility controls were obtained by comparison of signatures between duplicate samples. Tx:
treatment. The JC results shown in the box “reference strains” were obtained from the comparison of the Ms from the Dm28c, SilvioX10, gal4, and CMA strains. P
values indicate significant differences between populations (Mann-Whitney U test; p<0.05). Data in the boxplot are presented as median and interquartile range of 25
to 75%.April 2021 | Volume 11 | Article 665063
Muñoz-Calderón et al. Oral Chagas Disease Parasite Diversitywould have also allowed us to evaluate in greater detail the
response of these parasitic populations after the etiological
treatment. These limitations must be taken in account when
designing future studies. In conclusion, our serological and
molecular parasitological findings suggest that synergistic
multiple factors, such as the existence of clones with natural
drug resistance, selective pressure exerted by trypanomicidal
treatment, existence of dormant subpopulations, and evolution
of acute oral infection to its chronic phase may account for the
persistence of seroreactivity and parasite diversity in this patient
cohort after almost a decade of follow-up.DATA AVAILABILITY STATEMENT
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Schijman, A., et al. (2019). Longitudinal Follow Up of Serological Response in
Children Treated for Chagas Disease. PloS neglected Trop. Dis. 13 (8),
e0007668. doi: 10.1371/journal.pntd.0007668
Muñoz-Calderón, A., Dıáz-Bello, Z., Ramıŕez, J. L., Noya, O., and Alarcón de
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and Schijman. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal is
cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.April 2021 | Volume 11 | Article 665063
